INHATARGET THERAPEUTICS
InhaTarget Therapeutics is a spin-off company project from the University of Brussels (‘ULB’), which has received financial support from the Walloon Region (more than €500k) to (i) validate of the proof-of-concept of its chemotherapy DPI products and (ii) structure the company activities.
INHATARGET THERAPEUTICS
Founded:
2018-01-01
Address:
Bruyelle, Hainaut, Belgium
Country:
Belgium
Website Url:
http://www.inhatarget.com
Total Employee:
1+
Status:
Active
Contact:
+32 (0)2 650 52 54
Email Addresses:
[email protected]
Similar Organizations
Isarna Therapeutics
Isarna Therapeutics is a biotechnology company.
Current Employees Featured
Official Site Inspections
http://www.inhatarget.com Semrush global rank: 6.39 M Semrush visits lastest month: 1.06 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "InhaTarget Therapeutics"
Inhatarget
InhaTarget Therapeutics is a spin-off company from the University of Brussels (ULB) - Belgium, dedicated to the early development and clinical validation of innovative treatments of pulmonary diseases by inhalation, with a first focus …See details»
About Inhatarget Therapeutics : Mission and Expertise
InhaTarget Therapeutics is a spin-off company from the University of Brussels (ULB) - Belgium, dedicated to the early development and clinical validation of innovative treatments of pulmonary diseases by inhalation, with a first focus …See details»
InhaTarget Therapeutics - Crunchbase Company Profile & Funding
InhaTarget Therapeutics is a spin-off company project from the University of Brussels (‘ULB’), which has received financial support from the Walloon Region (more than €500k) to (i) validate …See details»
InhaTarget Therapeutics - LinkedIn
Today, Inhatarget Therapeutics participated to the 12th inter-entreprise Jogging event organized by Association ELA.This event helps rising funds for leukodystrophies, a group of rare genetic ...See details»
InhaTarget Therapeutics Overview | SignalHire Company Profile
InhaTarget Therapeutics is a spin-off company project from the University of Brussels (‘ULB’), which has received financial support from the Walloon Region (more than €500k) ...See details»
InhaTarget Thereapeutics - Products, Competitors, Financials, …
InhaTarget Therapeutics primarily serves the pharmaceutical sector with its custom development services for inhalation products, from pre-formulation to clinical proof-of-concept. It was …See details»
InhaTarget Therapeutics - Overview, News & Similar companies
Who is InhaTarget Therapeutics. InhaTarget is currently developing two anticancer DPIs to cover the gap between localized treatments (i.e. surgery and radiotherapy) and systemic t reatments …See details»
Inhatarget Therapeutics Company Profile | Charleroi, Belgium ...
Find company research, competitor information, contact details & financial data for Inhatarget Therapeutics of Charleroi. Get the latest business insights from Dun & Bradstreet.See details»
InhaTarget Therapeutics - VentureRadar
InhaTarget Therapeutics develops innovative and targeted dry powders for inhalation (DPI) that aim to improve the treatment of severe and/or chronic respiratory diseases. InhaTarget is …See details»
InhaTarget Therapeutics - BioWin
Jun 17, 2021 InhaTarget Therapeutics. Marine Divincenzo June 17, 2021 March 20th, 2023. Inhatarget Therapeutics is a ULB spin-off company dedicated to the early development of …See details»
InhaTarget Therapeutics - PitchBook
InhaTarget Therapeutics General Information Description. Developer of an inhalable powdered medicine designed to improve lung cancer treatment. The company's product is a dry powder …See details»
InhaTarget Therapeutics - Contacts, Employees, Board Members, …
Organization. InhaTarget Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Contacts 4. ...See details»
Contact Inhatarget Therapeutics - Get in Touch with Us
InhaTarget Therapeutics SRL Rue Antoine de Saint-Exupéry, 2 B-6041, Gosselies Belgium . Brussels Office. InhaTarget Therapeutics SRL Boulevard du Triomphe Campus Plaine ULB, …See details»
InhaTarget: chemotherapy by inhalation - BioPark
Mar 26, 2020 InhaTarget Therapeutics is developing a new route of administration of cisplatin (CIS) through dry particles for inhalation (DPI). What makes CIS-DPI so unique? ‘The active …See details»
Inhaled chemotherapy: changing the face of lung cancer treatment
Feb 26, 2020 More information at www.inhatarget.com or by email to [email protected]. References. 1 Souquet and Couraud. 2019. The Lancet Oncology 2 Rosière et al. 2019. …See details»
Baptiste Mingers - inhatarget.com
Active in analytical chemistry and inhalation product characterization for more than one year at InhaTarget Therapeutics. Meet the other members. Frédéric De Coninck. Management & …See details»
Targeted inhalation technology for severe respiratory diseases
InhaTarget Therapeutics is dedicated to the development of innovative formulations for inhalation to significantly improve the therapeutic outcome of existing drugs for the benefit and the quality …See details»
Inhatarget - Sambrinvest
Le positionnement n’est pas un substitut aux traitements standards actuels mais propose une solution addum par rapport aux traitements standards existants. Dans des cas spécifiques de …See details»
Inhaled chemotherapy for lung cancer - inhatarget.com
The goal of InhaTarget Therapeutics is to propose, via the inhalation route and through specific formulations, a similar panel of drugs to all these patient populations to significantly improve …See details»
Latest News in Inhalation Therapy - Inhatarget Therapeutics
InhaTarget Therapeutics at the European Society for Medical Oncology European Lung Cancer Congress 2023. January 11, 2023. InhaTarget Therapeutics is featured in this article on …See details»